San Diego lab agrees to pay $3M in fraud case

By LabPulse.com staff writers

October 5, 2020 -- San Diego-based drug testing firm Phamatech and its founder and CEO Tuan Pham have agreed to pay $3 million to settle Medicare fraud claims.

In an alleged two-year scheme, Phamatech paid Imperial Valley Wellness (IVW) medical group a per-specimen fee to submit Medicare beneficiaries' laboratory drug testing orders to the company. Many samples referred to Phamatech by IVW were also not medically necessary and, as a result, not eligible for Medicare reimbursement, according to the U.S. Department of Justice (DOJ).

In a statement, the DOJ said the actions of Phamatech and Tuan Pham violated federal laws preventing paid kickbacks and false claims. The DOJ also noted it first learned of the allegations in a lawsuit from a former Phamatech employee.

The settlement totaled $3,043,484, according to the DOJ. The whistleblower employee will receive $517,392 in proceeds.

Mammaprint maker settles Medicare fraud lawsuit for $8M
The maker of a popular genetic test that analyzes a patient's risk of breast cancer recurrence has agreed to pay an $8.25 million settlement for...
FDA pulls plug on wayward coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) has published the names of 28 coronavirus antibody tests that may no longer be marketed or distributed, as...
Medicare genetic testing fraud spurs federal charges
Thirty-five individuals have been charged in relation to more than $2.1 billion in fraudulent billing for expensive, unnecessary genetic cancer testing...
Path lab firm to pay $64M penalty for referral payments
Pathology laboratory company Inform Diagnostics has agreed to pay $63.5 million to settle allegations that it paid referring physicians for referrals,...

Copyright © 2020 LabPulse.com

Last Updated ls 10/5/2020 5:10:51 PM